Market Research Future has added a report titled “Actinic Keratosis Treatment Market
Research Report- Forecast to 2024” to its offering. The report provides an in-depth analysis
of regional data and an accurate projection of the market size and share of the Top 10
market players across the globe.
Report Overview:
Rise in the diagnosis efficiency of various types of cancers especially those related to the
skin such as actinic keratosis are growing promptly. The treatment of actinic keratosis is
gaining increasing prominence due to an extensive range of factors that are contributing to
the expansion of the market. Actinic keratosis is a commonly diagnosed skin disorder that
can potentially progress to non-melanoma skin cancers, this particular characteristic of the
disease has contributed to the demand for its treatment significantly. A typical patient
example with actinic keratosis is usually observed as having fair and sun-sensitive skin.
Owing to rapidly growing global demand levels, the actinic keratosis treatment market is
expected to develop with a CAGR of 4.20% in the duration of the forecast period. The global
market for actinic keratosis is set to increase its revenue share to USD 6,088.4 million in
2024 from USD 4,591.4 million in 2017. Observing the demand trends prevalent in the
market, many companies have initiated placebo trial for actinic keratosis. The upswing in
the number of cases for actinic keratosis has also spurred action from government and drug
regulating authorities to initiate field-directed treatment of actinic keratosis in different
regions of the world. The factors attributed to the expansion of the market globally are
mounting occurrence of actinic keratosis cases, increasing recognition of minimally invasive
therapeutic methods, escalating geriatric population and the availability of suitable medical
attention are among the crucial drivers for market growth. The market is also projected to
witness a rising demand trend for therapeutics. However, cryotherapy, topical medications,
laser therapy, and photodynamic therapy have also been observed as favored methods of
treatment that are powering the progress of the market in the forecast period.
Get Premium Copy @ https://www.marketresearchfuture.com/sample_request/2366
The betterment of the medical reimbursement policies in care facilities around the globe has
created an effective impact on the development of the market. Furthermore, the upgraded
caregiving arrangement in nations such as India and China have resulted in an uptick in
demand for actinic keratosis treatment in these nations. The growth of the market is
however motivated by its growing importance both in terms of detection and treatment,
particularly, in geographies such as the America and the European region. The collective
combination of these factors is projected to create a conducive environment for market
growth that will lead to exceptional growth in the upcoming forecast period.
Competitive Analysis:
The force of the market’s growth has transformed the competitive backdrop of the market.
The competitors in the market are also leveraging their competitive gains to safeguard their
growth in the market. The market expansion by competitors also encompasses strong risk
management strategies which will give smart returns. Cipher Pharmaceuticals Inc.,
BioLineRx, Valeant Pharmaceuticals, Biofrontera AG, Leo Pharma, 3M, Alma Lasers, Sun
Pharmaceutical Industries Ltd., and Stanford Chemicals are a few of the key players profiled
in the report.
Segmental Analysis:
The segment based analysis of the market are based on end-user, type, and region. The
end-user industries segment of the market comprises of dermatology clinics, hospitals,
oncology centers, and ambulatory surgical center. On type basis is segmented into
procedures and medications. The medication segment of the market additionally comprises
of imiquimod cream, fluorouracil cream, ingenol mebutate gel and diclofenac gel and the
procedures segment is additionally covers photodynamic therapy, laser, cryotherapy,
chemical peel and others.
Detailed Regional Analysis: